AstraZeneca to Buy China's Gracell Bio for up to $1.2 Billion https://ift.tt/DujJaOk cash deal, which adds several experimental therapies to AstraZeneca's portfolio, values Gracell at $2 per ordinary share, or $10 per ADS of Gracell, plus a non-tradable contingent value right of $0.30 per ordinary share, if certain regulatory milestones are met.
Tuesday, December 26, 2023
Subscribe to:
Post Comments (Atom)
-
Bechtel - Haryana - New Delhi - Requisition ID: 214786 Geotechnical Engineer with Bachelor’s Degree in Civil Engineering and 10 + years of e...
-
Top 5 way How to Search for a Job Online As Internet job boards continue to evolve, it can pay to stay current on the latest search to... -
Amazon - New River, AZ - Warehouse and Shopper Team Members Location: Goodyear, Phoenix Job opportunities vary by location. We update postin...
Posts
No comments:
Post a Comment